86
Participants
Start Date
June 6, 2022
Primary Completion Date
January 17, 2024
Study Completion Date
February 23, 2024
SAGE-718-matching placebo
Oral capsules
SAGE-718
Oral capsules
Sage Investigational Site, New York
Sage Investigational Site, Woodmere
Sage Investigational Site, Albany
Sage Investigational Site, Williamsville
Sage Investigational Site, Virginia Beach
Sage Investigational Site, Raleigh
Sage Investigational Site, Decatur
Sage Investigational Site, Port Orange
Sage Investigational Site, Orlando
Sage Investigational Site, Hialeah
Sage Investigational Site, Miami
Sage Investigational Site, Boca Raton
Sage Investigational Site, Boca Raton
Sage Investigational Site, Tampa
Sage Investigational Site, Tampa
Sage Investigational Site, Nashville
Sage Investigational Site, Memphis
Sage Investigational Site, Columbus
Sage Investigational Site, Toledo
Sage Investigational Site, Cincinnati
Sage Investigational Site, Madison
Sage Investigational Site, Bloomington
Sage Investigational Site, Chicago
Sage Investigational Site, Kansas City
Sage Investigational Site, Little Rock
Sage Investigational Site, Houston
Sage Investigational Site, San Antonio
Sage Investigational Site, Englewood
Sage Investigational Site, Sun City
Sage Investigational Site, Las Vegas
Sage Investigational Site, Los Angeles
Sage Investigational Site, Long Beach
Sage Investigational Site, Reseda
Sage Investigational Site, Fresno
Sage Investigational Site, Sacramento
Sage Investigational Site, Vernon
Sage Investigational Site, Stony Brook
Sage Investigational Site, Burlington
Supernus Pharmaceuticals, Inc.
INDUSTRY